233 related articles for article (PubMed ID: 27221039)
1. FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.
Bartel CA; Parameswaran N; Cipriano R; Jackson MW
Oncotarget; 2016 Aug; 7(32):52597-52612. PubMed ID: 27221039
[TBL] [Abstract][Full Text] [Related]
2. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
Mol Cancer Res; 2014 Aug; 12(8):1156-65. PubMed ID: 24736947
[TBL] [Abstract][Full Text] [Related]
3. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.
Snijders AM; Lee SY; Hang B; Hao W; Bissell MJ; Mao JH
Mol Oncol; 2017 Feb; 11(2):167-179. PubMed ID: 28078827
[TBL] [Abstract][Full Text] [Related]
4. Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.
Jiang Y; Yu J; Zhu T; Bu J; Hu Y; Liu Y; Zhu X; Gu X
J Cancer; 2023; 14(10):1888-1903. PubMed ID: 37476189
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
[TBL] [Abstract][Full Text] [Related]
6. The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms.
Fulcher LJ; Bozatzi P; Tachie-Menson T; Wu KZL; Cummins TD; Bufton JC; Pinkas DM; Dunbar K; Shrestha S; Wood NT; Weidlich S; Macartney TJ; Varghese J; Gourlay R; Campbell DG; Dingwell KS; Smith JC; Bullock AN; Sapkota GP
Sci Signal; 2018 May; 11(531):. PubMed ID: 29789297
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment.
Yuan S; Huang Z; Qian X; Wang Y; Fang C; Chen R; Zhang X; Xiao Z; Wang Q; Yu B; Li Y
Front Genet; 2022; 13():919559. PubMed ID: 35938024
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream Effectors.
Kim Y; Apetri M; Luo B; Settleman JE; Anderson KS
Mol Cancer Res; 2015 Apr; 13(4):765-74. PubMed ID: 25573954
[TBL] [Abstract][Full Text] [Related]
9. The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms.
Bozatzi P; Sapkota GP
Biochem Soc Trans; 2018 Jun; 46(3):761-771. PubMed ID: 29871876
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for oncogenic activation of the epidermal growth factor receptor.
Zandi R; Larsen AB; Andersen P; Stockhausen MT; Poulsen HS
Cell Signal; 2007 Oct; 19(10):2013-23. PubMed ID: 17681753
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
13. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
[TBL] [Abstract][Full Text] [Related]
14. Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling.
Minamoto T; Ougolkov AV; Mai M
Expert Rev Mol Diagn; 2002 Nov; 2(6):565-75. PubMed ID: 12465453
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of transformation by the v-rel oncogene.
Hannink M; Temin HM
Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
[TBL] [Abstract][Full Text] [Related]
17. Novel oncoprotein EPS8: a new target for anticancer therapy.
Li YH; Xue TY; He YZ; Du JW
Future Oncol; 2013 Oct; 9(10):1587-94. PubMed ID: 24106906
[TBL] [Abstract][Full Text] [Related]
18. Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis.
Bertotti A; Comoglio PM; Trusolino L
Cancer Res; 2005 Dec; 65(23):10674-9. PubMed ID: 16322210
[TBL] [Abstract][Full Text] [Related]
19. [The IKKε kinase in breast cancer: from oncogenesis to treatment resistance].
Grandvaux N
Med Sci (Paris); 2011; 27(6-7):619-25. PubMed ID: 21718646
[TBL] [Abstract][Full Text] [Related]
20. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
